Featured 13F manager
Viking Global Investors LP Andreas Halvorsen
Stamford, CT 22 processed 13Fs on this site · 2021 Q3–2026 Q2
- $35.1B
- 90 Positions
- 2026 Q2
- −1.9% QoQ
- Top 5 21.8%
Portfolio
top 5 21.8% · top 10 35.7%
- V - VISA · CL A 6.2%
- TSM - Taiwan Semiconductor 4.3%
- APD - Air Products 4.0%
- SHW - Sherwin Williams 3.8%
- FTV - Fortive 3.5%
- META - Meta Platforms · CL A 3.0%
- SCHW - Schwab Charles 2.8%
- TMO - Thermo Fisher Scientific 2.8%
- JPM - Jpmorgan Chase & 2.7%
- LII - Lennox Intl 2.6%
- AMZN - Amazon 2.5%
- RACE - Ferrari 2.3%
- Other 59.5%
AUM over time
Book
| V - VISA · CL A | 6.94% | Add +13.4% | 6,560,069 | $225.46 | $1.5B | +775,098 | +$277M |
| MCK - Mckesson | 5.36% | Add +45.5% | 3,207,080 | $356.05 | $1.1B | +1,002,662 | +$315M |
| UNH - Unitedhealth Group | 4.66% | Add +65.7% | 2,099,991 | $472.59 | $992M | +832,288 | +$320M |
| ELV - Elevance Health | 4.65% | Add +15.1% | 2,154,556 | $459.81 | $991M | +282,380 | +$30M |
| GE - GE Aerospace | 3.86% | Add +10.8% | 8,612,232 | $95.60 | $823M | +837,055 | +$172M |
| FTNT - Fortinet | 3.70% | Add +66.6% | 11,875,384 | $66.46 | $789M | +4,748,557 | +$441M |
| AMZN - Amazon | 3.70% | Reduce −38.9% | 7,628,220 | $103.29 | $788M | −4,853,738 | −$261M |
| APG - API Group | 3.60% | Add +0.8% | 34,090,285 | $22.48 | $766M | +270,718 | +$130M |
| LULU - Lululemon Athletica | 3.24% | New | 1,893,883 | $364.19 | $690M | +1,893,883 | +$690M |
| META - Meta Platforms · CL A | 3.21% | Add +35.3% | 3,229,914 | $211.94 | $685M | +842,184 | +$397M |
| CB - Chubb | 3.16% | Reduce −3.2% | 3,466,740 | $194.18 | $673M | −113,388 | −$117M |
| CSX - CSX Corp | 3.10% | Add +41.9% | 22,057,119 | $29.94 | $660M | +6,508,996 | +$179M |
| ROIV - Roivant Sciences | 3.06% | Hold | 88,238,700 | $7.38 | $651M | — | — |
| HDB - Hdfc Bank | 2.59% | Reduce −3.3% | 8,285,627 | $66.67 | $552M | −285,113 | −$34M |
| INTU - Intuit | 2.55% | Add +3.3% | 1,221,094 | $445.83 | $544M | +39,397 | +$84M |
| SHW - Sherwin Williams | 2.38% | New | 2,252,060 | $224.77 | $506M | +2,252,060 | +$506M |
| TMO - Thermo Fisher Scientific | 2.32% | Add +2.1% | 856,836 | $576.37 | $494M | +17,310 | +$32M |
| BBIO - Bridgebio Pharma | 2.07% | Hold | 26,620,991 | $16.58 | $441M | — | — |
| FTV - Fortive | 2.03% | Add +63.1% | 6,346,528 | $68.17 | $433M | +2,455,928 | +$183M |
| RPRX - Royalty Pharma · CLASS A | 1.89% | Add +11.9% | 11,204,249 | $36.03 | $404M | +1,195,738 | +$8M |
| STX - Seagate | 1.71% | Reduce −11.0% | 5,513,957 | $66.12 | $365M | −684,976 | +$38M |
| MSFT - Microsoft | 1.42% | Reduce −69.5% | 1,047,352 | $288.30 | $302M | −2,381,775 | −$520M |
| MA - Mastercard · CL A | 1.36% | Reduce −53.4% | 796,740 | $363.41 | $290M | −912,488 | −$305M |
| AMP - Ameriprise Finl | 1.35% | Reduce −42.9% | 941,040 | $306.50 | $288M | −706,815 | −$225M |
| Karuna Therapeutics | 1.28% | Add +26.8% | 1,501,074 | $181.64 | $273M | +317,338 | +$40M |
| ADPT — | 1.24% | Hold | 29,993,708 | $8.83 | $265M | — | — |
| VVV - Valvoline | 1.21% | Add +51.7% | 7,398,713 | $34.94 | $259M | +2,521,933 | +$99M |
| RCI - Rogers Comms B | 1.21% | Add +27.0% | 5,554,500 | $46.35 | $257M | +1,179,356 | +$53M |
| CDNS - Cadence Design System | 1.21% | Add +8.0% | 1,225,306 | $210.09 | $257M | +91,005 | +$75M |
| ACHC — | 1.14% | Add +6.1% | 3,354,110 | $72.25 | $242M | +192,996 | −$18M |
| BMRN - Biomarin Pharmaceutical | 0.99% | Reduce −58.9% | 2,168,617 | $97.24 | $211M | −3,105,003 | −$335M |
| EMR - Emerson Elec | 0.98% | New | 2,400,879 | $87.14 | $209M | +2,400,879 | +$209M |
| Ginkgo Bioworks · CL A | 0.89% | Add +126.8% | 143,085,126 | $1.33 | $190M | +80,000,000 | +$84M |
| MU - Micron Technology | 0.81% | Reduce −65.8% | 2,856,599 | $60.34 | $172M | −5,502,109 | −$245M |
| UNM - UNUM Group | 0.79% | Add +24.0% | 4,253,413 | $39.56 | $168M | +822,139 | +$27M |
| GTM - Zoominfo Technologies | 0.77% | New | 6,666,576 | $24.71 | $165M | +6,666,576 | +$165M |
| XYZ - Block · CL A | 0.76% | Reduce −47.5% | 2,354,123 | $68.65 | $162M | −2,129,631 | −$120M |
| CEG - Constellation Energy | 0.75% | New | 2,047,688 | $78.50 | $161M | +2,047,688 | +$161M |
| MOH - Molina Healthcare | 0.75% | Add +1.1% | 594,553 | $267.49 | $159M | +6,345 | −$35M |
| PGR - Progressive | 0.67% | Add +197.9% | 1,003,562 | $143.06 | $144M | +666,701 | +$100M |
| WDAY - Workday · CL A | 0.62% | New | 642,447 | $206.54 | $133M | +642,447 | +$133M |
| Inhibrx | 0.59% | Hold | 6,639,199 | $18.87 | $125M | — | — |
| CPNG - Coupang · CL A | 0.56% | New | 7,421,453 | $16.00 | $119M | +7,421,453 | +$119M |
| EQH - Equitable | 0.48% | Reduce −23.5% | 3,989,446 | $25.39 | $101M | −1,223,014 | −$48M |
| KBR - KBR Inc | 0.43% | Add +55.9% | 1,679,474 | $55.05 | $92M | +602,174 | +$36M |
| AMLX - Amylyx Pharmaceuticals | 0.41% | Reduce −36.1% | 2,962,555 | $29.34 | $87M | −1,672,051 | −$84M |
| RIVN - Rivian Automotive · CL A | 0.38% | New | 5,250,417 | $15.48 | $81M | +5,250,417 | +$81M |
| INSP - Inspire Med Sys | 0.38% | Reduce −37.0% | 346,576 | $234.07 | $81M | −203,217 | −$57M |
| CRL - Charles Riv Labs Intl | 0.37% | Reduce −23.5% | 394,089 | $201.82 | $80M | −121,079 | −$33M |
| SNPS - Synopsys | 0.37% | New | 205,032 | $386.25 | $79M | +205,032 | +$79M |
| Catalent | 0.37% | Reduce −15.7% | 1,201,210 | $65.71 | $79M | −223,178 | +$15M |
| ALKS - Alkermes | 0.37% | New | 2,781,917 | $28.19 | $78M | +2,781,917 | +$78M |
| ZLAB - Zai Lab | 0.36% | Add +18.1% | 2,331,245 | $33.26 | $78M | +357,648 | +$17M |
| IFF - International Flavors & Fragrances | 0.35% | Add +85.0% | 812,680 | $91.96 | $75M | +373,320 | +$29M |
| FDMT — | 0.32% | Hold | 3,937,914 | $17.19 | $68M | — | — |
| TRV - Travelers Companies | 0.30% | New | 378,345 | $171.41 | $65M | +378,345 | +$65M |
| GH - Guardant Health | 0.28% | Reduce −38.2% | 2,538,889 | $23.44 | $60M | −1,568,755 | −$52M |
| SNOW - Snowflake · CL A | 0.28% | New | 382,757 | $154.29 | $59M | +382,757 | +$59M |
| INTC - Intellia Therapeutics | 0.27% | Reduce −22.4% | 1,569,545 | $37.27 | $58M | −451,865 | −$12M |
| BSX - Boston Scientific | 0.27% | Reduce −88.1% | 1,136,881 | $50.03 | $57M | −8,391,712 | −$384M |
| NAMS - Newamsterdam Pharma | 0.25% | Add +4.3% | 3,915,870 | $13.44 | $53M | +162,042 | +$13M |
| CL - Colgate Palmolive | 0.23% | New | 660,698 | $75.15 | $50M | +660,698 | +$50M |
| DELL - DELL Technologies · CL C | 0.21% | New | 1,094,394 | $40.21 | $44M | +1,094,394 | +$44M |
| CNH - Cnh Indl | 0.20% | New | 2,827,515 | $15.27 | $43M | +2,827,515 | +$43M |
| MMC - Marsh & Mclennan Cos | 0.20% | New | 257,443 | $166.55 | $43M | +257,443 | +$43M |
| Farfetch · CL A | 0.16% | Add +4.9% | 7,103,457 | $4.91 | $35M | +332,222 | +$3M |
| OPCH - Option Care Health | 0.16% | New | 1,090,497 | $31.77 | $35M | +1,090,497 | +$35M |
| EWTX - Edgewise Therapeutics | 0.15% | Add +11.3% | 4,909,146 | $6.67 | $33M | +500,000 | −$7M |
| VKTX - Viking Therapeutics | 0.15% | New | 1,955,063 | $16.65 | $33M | +1,955,063 | +$33M |
| TJX - Tjx Cos | 0.15% | New | 414,401 | $78.36 | $32M | +414,401 | +$32M |
| PHVS - Pharvaris | 0.12% | Hold | 3,231,923 | $7.82 | $25M | — | — |
| Rallybio | 0.11% | Hold | 4,194,777 | $5.71 | $24M | — | — |
| DAWNGBX — | 0.10% | Hold | 1,558,563 | $13.37 | $21M | — | — |
| PEPG - Pepgen | 0.09% | Hold | 1,544,631 | $12.23 | $19M | — | — |
| Kinnate Biopharma | 0.05% | Hold | 1,820,462 | $6.25 | $11M | — | — |
| TRVI - Trevi Therapeutics | 0.04% | Hold | 4,400,000 | $1.85 | $8M | — | — |
| Lianbio | 0.03% | Hold | 3,564,173 | $1.95 | $7M | — | — |
| Talaris Therapeutics | 0.03% | Hold | 3,289,617 | $1.88 | $6M | — | — |
| Holding | 0.02% | New | 276,260 | $13.99 | $4M | +276,260 | +$4M |
| Verastem | 0.02% | Hold | 9,224,000 | $0.4152 | $4M | — | — |
Showing top 50 of 80 by value
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2022 Q4
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| BN - Brookfield · CL A | 1.14% | Exit | 0 | $31.46 | $228M | −7,262,078 | −$228M |
| RH | 1.00% | Exit | 0 | $267.19 | $200M | −748,344 | −$200M |
| UBER - UBER Technologies | 0.98% | Exit | 0 | $24.73 | $196M | −7,939,999 | −$196M |
| LI - Li Auto | 0.93% | Exit | 0 | $20.40 | $185M | −9,090,065 | −$185M |
| AIG - American Intl Group | 0.82% | Exit | 0 | $63.24 | $164M | −2,590,026 | −$164M |
| AMD - Advanced Micro Devices | 0.62% | Exit | 0 | $64.77 | $123M | −1,905,600 | −$123M |
| BEKE - KE | 0.56% | Exit | 0 | $13.96 | $113M | −8,084,334 | −$113M |
| CLX - Clorox Del | 0.54% | Exit | 0 | $140.33 | $108M | −768,839 | −$108M |
| PODD - Insulet | 0.40% | Exit | 0 | $294.39 | $79M | −268,052 | −$79M |
| DG - Dollar Gen | 0.38% | Exit | 0 | $246.25 | $77M | −310,848 | −$77M |
| CRWD - Crowdstrike · CL A | 0.37% | Exit | 0 | $105.29 | $74M | −699,948 | −$74M |
| ALB - Albemarle | 0.37% | Exit | 0 | $216.86 | $73M | −337,339 | −$73M |
| Capri | 0.23% | Exit | 0 | $57.32 | $46M | −810,479 | −$46M |
| RRX - Regal Rexnord | 0.22% | Exit | 0 | $119.98 | $43M | −362,403 | −$43M |
| Shockwave Med | 0.17% | Exit | 0 | $205.61 | $34M | −164,607 | −$34M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 90 | $35.1B | −1.9% | 13F-HR | 8/14/2026 | 000110380426000006 |
| 2026 Q1 | 77 | $35.7B | −5.1% | 13F-HR | 5/15/2026 | 000110380426000004 |
| 2025 Q4 | 76 | $37.7B | −2.1% | 13F-HR | 2/17/2026 | 000110380426000002 |
| 2025 Q3 | 78 | $38.5B | +11.3% | 13F-HR | 11/14/2025 | 000110380425000010 |
| 2025 Q2 | 83 | $34.6B | +9.9% | 13F-HR | 8/14/2025 | 000110380425000007 |
| 2025 Q1 | 91 | $31.5B | +1.9% | 13F-HR | 5/15/2025 | 000110380425000004 |
| 2024 Q4 | 86 | $30.9B | +12.6% | 13F-HR | 2/14/2025 | 000110380425000002 |
| 2024 Q3 | 83 | $27.4B | +5.4% | 13F-HR | 11/14/2024 | 000110380424000006 |
| 2024 Q2 | 82 | $26B | −3.1% | 13F-HR | 8/14/2024 | 000090514824002226 |
| 2024 Q1 | 83 | $26.9B | −1.6% | 13F-HR | 5/15/2024 | 000110380424000004 |
| 2023 Q4 | 79 | $27.3B | +10.8% | 13F-HR | 2/14/2024 | 000110380424000002 |
| 2023 Q3 | 80 | $24.6B | +0.9% | 13F-HR | 11/14/2023 | 000110380423000009 |
| 2023 Q2 | 86 | $24.4B | +14.6% | 13F-HR | 8/14/2023 | 000110380423000006 |
| 2023 Q1 | 81 | $21.3B | +6.7% | 13F-HR | 5/15/2023 | 000110380423000004 |
| 2022 Q4 | 76 | $20B | −7.8% | 13F-HR | 2/14/2023 | 000110380423000002 |
| 2022 Q3 | 88 | $21.7B | −0.9% | 13F-HR | 11/14/2022 | 000110380422000006 |
| 2022 Q2 | 82 | $21.9B | −11.6% | 13F-HR | 8/15/2022 | 000110380422000004 |
| 2022 Q1 | 91 | $24.7B | −28.3% | 13F-HR | 5/16/2022 | 000110380422000003 |
| 2021 Q4 | 107 | $34.7B | — | RESTATEMENT | 5/16/2022 | 000156761922010954 |
| 2021 Q4 | 107 | $34.5B | −4.3% | 13F-HR | 2/14/2022 | 000110380422000002 |
| 2021 Q3 | 96 | $36.5B | — | RESTATEMENT | 5/16/2022 | 000156761922010950 |
| 2021 Q3 | 96 | $36B | — | 13F-HR | 11/15/2021 | 000110380421000009 |
About
VIKING GLOBAL INVESTORS LP
22 processed 13Fs on this site · 2021 Q3–2026 Q2